Update: Today's tactical trade is delivering

It surged after this morning’s alert

August 03, 2026

*contains promoted content

Good afternoon, Folks,

A few hours ago, I sent you my latest “tactical trade” idea centered on a biotech with an unusual approach to treating skin cancer.

If you caught the email and watched the action this morning, congratulations!

The stock has climbed sharply today, gaining more than 15% at one point, and it's been one of the stronger movers on my screen.

It didn’t hurt that this morning, the company highlighted Chief Medical Officer Dr. Faisal Mehmud, whose background includes senior leadership roles at Pfizer, GlaxoSmithKline, Bristol Myers Squibb, Novartis, and Sanofi. 

The news this morning was his additional appointment as CEO of Antev Limited, the company's United Kingdom subsidiary.

Dr. Mehmud got his medical degree from Cambridge and has spent more than two decades helping develop and bring new therapies through the clinical and regulatory process.

Whether you've already been following along or you're just now seeing today's move, I don't think this is a story to lose sight of.

The positive Phase 2 data, the recent FDA clearance for the registrational SkinJect study, and the additional developments we've seen over the past several months are why I highlighted this company in the first place.

I'll continue watching closely for the next catalyst, and if something meaningful develops, you'll be the first to know.

If you haven't had a chance to read this morning's writeup, click here for the full details.

To Your Success,

DISCLAIMER: This entity is owned by Sherwood Ventures LLC (SV). Full disclaimer https://bullseyealerts.com/disclaimer/. We are a financial publisher, not a registered investment advisor. Our content is for informational purposes only and should not be considered personalized investment advice. All trading involves substantial risk of loss and you may lose some or all of your invested capital. Past performance does not guarantee future results.

*ISSUER PAID PROMOTION/COMPENSATION DISCLOSURE: SV has received seventy five thousand dollars(cash) for a five day marketing program on August 3, 2026 (via LFG Equities Group) for marketing efforts to increase public awareness of the company mentioned on this page HERE. Please scroll to the bottom for full disclosure details including historical records (if applicable). As SV has received compensation from companies, these parties have financial interests in the securities referenced. SV and its affiliates may buy, sell, or hold positions in securities mentioned at any time without notice.